Diabetes :: FDA approves Continuous 7-Day Glucose Monitoring System
The U.S. Food and Drug Administration today approved a device that measures glucose levels continuously for up to seven days in people with diabetes.
Heart
Trans Fat :: Pan American Health calls for trans fat free Americas
The Pan American Health Organization (PAHO), a regional arm of the United Nations World Health Organization (WHO), called for the elimination of industrial trans fats from food supplies throughout the Americas in order to prevent heart attacks.
Stent :: FDA approves ostial pro stent positioning system
The Food and Drug Administration has given approval for a Kalamazoo, MI-based company to begin marketing a one-of-a-kind device that allows physicians to more accurately place a stent in selected coronary and renal procedures.
Diabetes :: New drug protects against diabetes and atherosclerosis
Blocking a single protein with an experimental drug prevented and treated both type 2 diabetes and atherosclerosis in laboratory mice that had been fed unhealthy diets and were genetically predisposed to these common killers, according to an article published online at Nature on June 6, 2007.
Heart :: Standards for measuring narrowing of carotid arteries too aggressive
Standards for the use of ultrasound as a screening tool to measure narrowing of the carotid artery may be too aggressive, resulting in some needless follow-up tests and procedures according to researchers at the University of Chicago Medical Center. Narrowing of the carotid can be a precursor to a stroke.
Rheumatoid Arthritis :: University of Manchester researchers reveal clues to new genes behind rheumatoid arthritis
Researchers at the University of Manchester have identified evidence of several new genes behind the chronic inflammatory disease rheumatoid arthritis (RA), which affects 387,000 people in the UK.
Heart disease :: Heart disease deaths fall, as obesity and diabetes increase, experts find
Epidemiologists at the University of Liverpool and the Heart of Mersey have found that approximately half the recent fall in coronary heart disease deaths in the US is due to positive life style changes and a further half to medical therapies.
Hernia :: Understanding and treating congenital diaphragmatic hernia
Four new reviews shed light on CHD by describing the diversity of the condition, exploring potential ways of treating it, using animal models to discover which genes play a role in diaphragm development, and examining its connection to cardiovascular malformations.
Sleep Apnea :: Longer treatment benefits sleep apnea patients
Adults with obstructive sleep apnea benefit significantly from longer nightly use of continuous positive airway pressure (CPAP), a device to improve breathing during sleep, according to a new study supported by the National Heart, Lung and Blood Institute of the National Institutes of Health. This is the first study to identify the nightly duration of CPAP use needed to gain maximum benefit for daytime alertness and functioning.
Diabetes :: FDA has requested black box warnings for two diabetes medications
FDA has requested a black box warning for the labels of the type 2 diabetes medications Avandia, manufactured by GlaxoSmithKline, and Actos, manufactured by Takeda Pharmaceuticals, because of increased risk for congestive heart failure associated with the medications, agency Commissioner Andrew von Eschenbach announced on Wednesday at a House Oversight and Government Reform Committee hearing, the New York Times reports.